TY  - JOUR
AU  - Arribas, Jose R.
AU  - Rubio García, Rafael
AU  - Pulido Ortega, Federico
PY  - 2009
DO  - 10.1097/QAI.0b013e3181a56de5
SN  - 1525-4135
UR  - https://hdl.handle.net/20.500.14352/107233
T2  - Journal of Acquired Immune Deficiency Syndrome
AB  - Background: The OK04 trial has shown that 48 weeks of lopinavir-ritonavir monotherapy with reintroduction of nucleosides as needed was noninferior to continuation of triple therapy with 2 nucleosides and lopinavir-ritonavir in patients with prior...
LA  - eng
M2  - 147
PB  - Lippincott Williams & Wilkins
KW  - Lopinavir-ritonavir
KW  - HIV
KW  - Antiretrovirales
TI  - Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis
TY  - journal article
VL  - 51
ER  -